Evidence map›Paper›PMID 31623263›Full record

ArticleNanomaterials (Basel, Switzerland)2019

Towards Blue Long-Lasting Luminescence of Eu/Nd-Doped Calcium-Aluminate Nanostructured Platelets via the Molten Salt Route.

Rocío E Rojas-Hernandez, Fernando Rubio-Marcos, Aida Serrano, Eduardo Salas, Irina Hussainova, José Francisco Fernandez

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Rocío E Rojas-HernandezElectroceramic Department, Instituto de Cerámica y Vidrio, CSIC, Kelsen 5, 28049 Madrid, Spain. rociorojas@icv.csic.es.
Fernando Rubio-MarcosElectroceramic Department, Instituto de Cerámica y Vidrio, CSIC, Kelsen 5, 28049 Madrid, Spain. frmarcos@icv.csic.es.
Aida SerranoElectroceramic Department, Instituto de Cerámica y Vidrio, CSIC, Kelsen 5, 28049 Madrid, Spain. aida.serrano@icv.csic.es.
Eduardo SalasSpanish CRG BM25 SpLine beamline, The European Synchrotron, 38043 Grenoble, France, and Instituto de Ciencia de Materiales de Madrid, CSIC, 28049 Madrid, Spain. edusc22@gmail.com.
Irina HussainovaDepartment of Materials Engineering, Tallinn University of Technology, Ehitajate 5, 19180 Tallinn, Estonia. irina.hussainova@taltech.ee.
José Francisco FernandezElectroceramic Department, Instituto de Cerámica y Vidrio, CSIC, Kelsen 5, 28049 Madrid, Spain. jfernandez@icv.csic.es.
Instituto de Cerámica y Vidrio · ESTallinn University of Technology · EEEuropean Synchrotron Radiation Facility · FRUniversidad Nebrija · ES

Funding

ENHANCEMENT OF THE ADDICTION SEVERITY INDEXR43DA005395 · NIDA · INTEGRA, INC. · PI GRISSOM, GRANT R · 1987 to 1987
–
ENHANCEMENT OF THE ADDICTION SEVERITY INDEXR44DA005395 · NIDA · INTEGRA, INC. · PI GRISSOM, GRANT R · 1990 to 1991
–
Comunidad de Madrid 2017-t2/IND5395Estonian Research Competency Council MOBJD254Estonian Research Competency Council PUT1063Ministerio de Ciencia, Innovación y Universidades MAT2017-86450-C4-1-RMinisterio de Ciencia, Innovación y Universidades RTI2018-095303-A-C52
6 · The paper itself

Abstract

Calcia-alumina binary compounds doped with rare earths and some transition metals cations show persistent luminescence from the visible to the infrared range. Specifically, the blue light can be obtained through the Eu

Indexed as

calcium-aluminatesmolten salt methodpersistent luminescencephosphorrare-earthXANES

Identifiers

PMID31623263
PMCPMC6836158
OpenAlexW2980871758

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.